The vaccine candidate, dubbed ASF-G-ΔMGF, was recently licensed for commercial development by Zoetis.

Modest worldwide growth is expected as the industry continues to reduce its environmental impact and mitigate disease impacts.

Understanding the risk environment and strategies for mitigating African swine fever.

Both organizations shared updates on regulatory requirements and processes, food safety and facility inspections.